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The Comprehensive Risk Assessment for Bypass (CRAB): An Efficient
Perioperative Risk Assessment Instrument for Patients With Critical
Limb Ischemia
Andrew J. Meltzer, MD,1 Ashley Graham,1 Peter H. Connolly, MD,1
Ellen C. Meltzer, MD,2 John K. Karwowski, MD,1 Harry L. Bush, MD,1
Darren B. Schneider, MD1. 1Vascular Surgery and 2Department of Public
Health, Weill Cornell Medical College, New York-Presbyterian Hospital,
New York, NY
Objective(s): Specific risk assessment models have been developed for
bariatric and colorectal procedures. A similar instrument, specific for patients
with critical limb ischemia (CLI), could improve patient-centered clinical
decisionmaking.We describe a novel tool to predict 30-daymajormorbidity
and mortality (M&M) after bypass surgery for CLI.
Methods: The 2007-2009 National Surgical Quality Improvement
Program patient data (N  4894) were analyzed to test 32 preoperative
factors for association with 30-day M&M. Significant predictors in multi-
variate models were assigned integer values (points), which were added to
calculate a patient’s comprehensive risk assessment for bypass (CRAB) score.
Performance was assessed (C-index) and compared with other tools (Amer-
ican Society of Anesthesiologists class, Surgical Risk Scale, and Prevent III
score) on a distinct validation sample of 1620 individuals.
Results:Overall, 921 patients (18.8%) suffered major morbidity and 144
(2.9%) died. The CRAB model included seven predictors of 30-day M&M
(Table). Applied to the validation sample, the CRAB score accurately predicted
morbidity and mortality rates: 14% and 1%, respectively, in low-risk patients
(CRAB2) vs 22% and 6% (CRAB 3-4) vs 31% and 15% in high-risk patients
(CRAB 5; P  .001). Accuracy of CRAB mortality prediction (C-index 
.76, P  .001) exceeded American Society of Anesthesiologists class (0.59),
Surgical Risk Scale (0.6), and Prevent III score (0.65). CRAB was the only
model to predict morbidity at a statistically significant level (P .01).
Conclusions: The CRAB is the first targeted risk assessment instrument
formorbidity andmortality after bypass surgery inCLI patients. The assessment
uses clinically relevant factors and a straightforward scoring system, it is superior
to other generalmodels for predictionofmortality, and is the only instrument to
predict major morbidity. This unique tool provides an evidence basis for patient-
centered clinical decision-making, andmay have a role at identifying patients at the
highest risk for surgery in whom an endovascular approach is preferable.
Table. CRAB score
Variable Points AOR (95% CI) P
Age 75 years 1 1.31 (1.09-1.59) .004
Dialysis dependence 1 1.49 (1.14-1.93) .003
Agnina within 6 months 1 1.54 (1.1-2.25) .02
Prior extremity
revascularization 1 1.42 (1.18-1.70) .001
Obesity 1 1.53 (1.26-1.86) .001
Emergency surgery 2 2.15 (1.42-3.25) .001
Functional dependence
Partial 2 1.79 (1.47-2.19) .001
Total 3 2.37 (1.34-4.17) .003
Total maximum points 10
AOR, Adjusted odds ratio; CI, confidence interval.
Efficacy and Cost-Effectiveness of Endovascular vs Conventional By-
pass Revascularization for Critical Limb Ischemia
Hannah J. Kim, Justin Boccardo, James Tretter. Conemaugh Memorial
Medical Center, Johnstown, Pa
Sponsored by Rabih A. Chaer, MD
Objective(s): This study is a review and evaluation of twomodalities of
revascularization for patients with critical limb ischemia—endovascular
(EV) and conventional bypass (CB) surgery—to identify efficacy and cost-
effectiveness by comparing reintervention rate, amputation rate, and total
cost to hospital in this particular group.
Methods: Retrospective review was performed for 214 cases in 192
patients with diagnosis of critical limb ischemia requiring revascularization
between 2007 and 2011. We evaluated reintervention rate and amputation
rate at 1, 3, 6, 12, and36months in primary EV vs CB surgery groups. The
total cost to the hospital was also compared in these groups.
Results: Between July 2007 and June 2011, Conemaugh Physicians
Group Vascular Surgery Department treated 214 limbs in 192 patients with
diagnosis of critical limb ischemia. CB surgery using vein graft was per-
formed in 84 limbs (39.3%), and EV primary revascularization, including
atherectomy, balloon angioplasty, and stent placement, was performed in
130 limbs (60.7%). The cumulative amputation rate in both groups was
13.1% at 36 months, of which 8.8% (19 limbs) were in the EV group, and
4.2% (nine limbs) were in the CB group (P  .671). The amputation rate
was 2.3%, 9.2%, 11.5%, 13%, and 14.5% in the EV group and 3.6%, 6%, 7.2%,
8.4%, 9.6%, and 10.8% in the CB group, respectively, at 1, 3, 6, 12, 24, and 36
months. The cumulative secondary intervention rate in both groups was 24% at
36 months. Of these, 12.6% were in the EV group and 11.7% were in the CB
group (P  .940). Secondary intervention rates were 5.4%, 10.8%, 14.6%,
19.2%, 20.0%, 20.9% in the EV group and 8.3%, 15.5%, 21.4%, 27.4%, 28.6%,
and 29.7% in the CB group at 1, 3, 6, 12, 24, and 36 months, respectively.
During 36 months of follow-up, more than two interventions for limb salvage
were required in 4.6% in the EV and in 8.3% in the CB group (P .268). Total
cost to the hospital for the first intervention was $27,365.03  $18,916.34
(range, $3,018-$119,518) in the EV group and $24,727.99 14,373.89
(range, $6,570-$70,282) in the CB groups (P .292).
Conclusions: In our experience, EV revascularization is as effective for
limb salvage and cost-effective as CB for the primary treatment of critical
limb ischemia.
Subsequent Open Surgical Revascularization Following an Initial En-
dovascular Approach for Critical Limb Ischemia
Rameen Moridzadeh, Patrick A. Kaszubski, Caron B. Rockman, MD,
Frank J. Veith, MD, Firas F. Mussa, MD. Department of Vascular Surgery,
New York University School of Medicine, New York, NY
Objective(s): Endovascular treatment (endoRx) is often used as the
initial treatment for critical limb ischemia. The goal of this study was to
examine the likelihood, predictors, and outcomes of open surgical (OS)
revascularization or reintervention after initial endoRx for critical limb
ischemia.
Methods: We retrospectively reviewed a prospectively collected data-
base from January 1, 2007, to December 31, 2010. Demographics, Ruth-
erford classification, prior procedures, secondary endoRx, and limb salvage
rates were analyzed. Statistical significance was determined by 2 and mul-
tivariate regression analysis with P  .025.
Results: Of the 302 study patients, 126 (41%) had initial OS; 158
(52%) had initial endoRx; and 21 (7%) had hybrid procedures. Of the 126
patients treated by initial OS, 57 (45%) required a secondary endoRx. Of the
158 patients who initially underwent endoRx, 71 (45%) required a second-
ary OS. Compared with those who were treated by initial OS, patients who
had OS after failed endoRx had worse limb salvage rates (odds ratio, 1.6;
95% confidence interval, 0.215-0.894, P  .023). A similar outcome was
seen in those who required repeat endoRx after a failed initial endoRx (odds
ratio, 1.25; 95% confidence interval, 0.104-0.505, P .0001). Diabetes and
tissue loss predicted need for OS after initial endoRx. Only diabetes pre-
dicted the need for repeated endoRx after a failed initial attempt. Overall
amputation rate was 14.9%. Renal failure and initial endoRx were predictors
of major amputation when controlling for all potential confounders.
Conclusions: Patients who require open OS revascularization or re-
peated endoRx after initial endoRx for CLI have worse limb salvage rates
than patients who undergo initial OS revascularization. Therefore, in select
patients in whom an appropriate surgical option exists, OS revascularization
should be considered as the initial therapy for critical limb ischemia.
Outcomes in the Elderly of Open and Endovascular Interventions for
Advanced Superficial Femoral Artery Occlusive Disease
Javier E. Anaya-Ayala, MD, Christopher J. Smolock, MD, Matthew K.
Adams, BS, Mitul S. Patel, MD, Cassidy Duran, MD, Charudatta S. Bavare,
MD, Hosam F. El-Sayed, MD, Alan B. Lumsden, MD, Mark G. Davies,
MD, PhD, MBA. Department of Cardiovascular Surgery, Methodist De-
Bakey Heart & Vascular Center, Houston, Tex
Objective(s): The number of patients aged80 years undergoing treat-
ment of symptomatic advanced femoropopliteal disease is increasing. This study
examined the clinical efficacy of these interventions in this specific population.
Methods: A database of patients undergoing open (OPEN) and endo-
luminal (ENDO) intervention for TransAtlantic Inter-Society Concensus
(TASC) II C and D femoropopliteal lesions between 1990 and 2010 was
retrospectively queried. Patients aged 80 years were selected. Kaplan-
Meier survival analyses were performed to assess time-dependent outcomes.
Factor analyses were performed using a Cox proportional hazard model for
time dependent variables.
Results: During the 20-year period, 2539 patients underwent OPEN
or ENDO treatment for symptomatic and anatomically advanced femoro-
popliteal disease (TASC II C and D); of these, 353 (14%) were aged 80
years (Table). There was a significant difference in the ages and modified
cardiac risk index between the two groups, with older and more high risk
patients undergoing ENDO. The groups had equivalent comorbidities and
survival. OPEN was more commonly performed on those with rest pain/
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tissue loss (Table). The 30-day major adverse cardiac and leg events were
equivalent in OPEN and ENDO. However, patients undergoing ENDO
had a higher 30-day amputation rate. Clinical efficacy, amputation-free
survival, and long-term major adverse leg events were equivalent between
the groups, with few patients surviving 5 years. Critical limb ischemia,
diabetes, end-stage renal disease, and poor tibial runoff were predictors of
outcomes in both groups.
Conclusions: Patients aged80 years offered OPEN or ENDO based
on the operator’s clinical opinion have equivalent perioperative and long-
term patient-centered outcomes.
Table.
OPEN ENDO P value
Number limbs at risk (n) 204 149
Male gender (%) 40% 48% .36
Age (years  SD) 84  4 85  4 .02
Modified Cardiac Risk Index 3.0  1.6 3.4  1.8 .03
Rest pain/tissue loss 68% 68% .01
30-day MACE 10% 7% .09
30-day MALE 10% 8% .2
30-day amputation 1% 5% .17
5-year MALE (mean  SEM) 64  4% 64  5% .74
5-year amputation free
survival (mean  SEM) 45  4% 37  5% .09
5-year clinical efficacy
(mean  SEM) 62  4% 47  6% .051
Endoscopic Versus Open Saphenous Vein Graft Harvest for Lower
Extremity Bypass in Critical Limb Ischemia (CLI)
Raymond Eid, MD, Li Wang, MS, Steven Leers, MD, Ghassan Abu-
Hamad, MD, Michel Makaroun, MD, Rabih Chaer, MD. University of
Pittsburgh Medical Center, Pittsburgh, Pa
Objective(s): Endoscopic vein harvest (EVH) has been demonstrated
to improve early morbidity compared with conventional open vein harvest
(OVH) technique for infrainguinal bypass surgery. Recent literature, how-
ever, suggests conflicting results regarding long-term patency between these
techniques. The purpose of this study was to compare outcomes and graft
patency in patients with critical limb ischemia (CLI).
Table. Outcomes among patients undergoing OVH versus EVH
Variable OVH EVH P
Procedures, n 49 39
Length of hospital stay 6.05  3.3 7.14  9.7 .26
Postoperative leg wound
infection (surgical
site  vein harvest
site) 11 (22.9%) 6 (16.2%) .31
Major amputations
(BKA/AKA) 4 (8.1%) 1 (2.5%) .34
Discharge disposition
Home 29 (59.1%) 26 (70.3%) .40
Nursing facility 20 (40.8%) 11 (29.7%) .57
Primary patency at one
year 69.4% 43.2% .007
Loss of primary patency: 15 (30.6%) 23 (58.9%)
Anastomotic stenosis 23% 18%
Graft occlusion 61% 22.7%
Vein body stenosis 0% 54.5%
Average # of
interventions/graft 0.37  0.85 1.28  1.59 .001
Methods: This retrospective study compared 39 EVH patients and 49
OVH patients undergoing lower extremity revascularization from January
2009 to December 2011. Outcome measures included patency rates, post-
operative complications, and wound infection. Graft patency was assessed
using Kaplan-Meier estimation and Cox proportional hazards models.
Results: Both groups were matched demographically and for indica-
tions for bypass (CLI). Median follow-up was 22.8 months. There were
differences in postoperative complications between the two groups. The
incidence of wound infection at the vein harvest site was 0% in EVH vs 20%
in OVH; nevertheless, the difference was not significant when all surgical
sites were included (22.9% OVH, 16.2% EVH). Length of hospital stay was
comparable between the two groups, although the EVH group had ten-
dency toward quicker recovery. Primary patency rate at 1 year was 43.2% in
the EVH group and 69.4% in the OVH group (P  .007). The most
common reason for loss of primary patency was graft occlusion (61.5%) in
the OVH group and vein body stenosis (54.5%) in the EVH group. The
average number of vascular reinterventions per bypass graft was significantly
lower in the OVH group (0.37) than in the EVH group (1.28; P  .001;
Table).
Conclusions: Our findings demonstrate an inferior patency, higher
rates of reinterventions, with a different mode of failure in patients under-
going EVH compared with OVH. Short-term benefits of EVH, including a
trend towards quicker recovery and lower rate of vein harvest site infection,
appear maintained.
Clinical Outcomes of Tibial Artery Endovascular Interventions in
End-Stage Renal Disease Patients on Hemodialysis
Javier E. Anaya-Ayala, MD, Christopher J. Smolock, MD, Matthew K.
Adams, BS, Monider Singh, BS, Mitul S. Patel, MD, Charudatta S. Bavare,
MD, Cassidy A. Duran, MD, Hosam F. El-Sayed, MD, Mark G. Davies,
MD, PhD, MBA. Department of Cardiovascular Surgery, Methodist De-
Bakey Heart and Vascular Center, Houston, Tex
Objective(s):Over the last decade, there has been a significant increase
in primary tibial endovascular interventions for critical limb ischemia (CLI;
rest pain and tissue loss) of the lower extremity. This study examines the
outcomes of end-stage renal disease (ESRD) patients on hemodialysis with
tissue loss.
Methods: A prospective database of patients undergoing tibial inter-
vention for CLI between 2000 and December 2011 was queried. Patients
with ESRD on hemodialysis with tissue loss were selected. Patient-centered
outcomes were evaluated, including clinical efficacy, defined as absence of
recurrent symptoms, maintenance of ambulation and absence of major
amputation; amputation-free survival (AFS), defined as survival without
major amputation; and freedom from major adverse limb events (MALE),
defined as above ankle amputation of the index limb or major reintervention
(repeat endoluminal intervention, new bypass graft, jump/interposition
graft revision).
Results:A total of 52 limbs in 46 hemodialyisis patients (59%male, age
66 12 years) underwent tibial artery interventions for CLI presenting with
tissue loss (Rutherford classification 5 and 6). Of these, 69% had isolated
tibial interventions and 31% had SFA and tibial interventions. Tibial Trans-
Atlantic Inter-Society Consensus lesions were A and B in 46% and C and D
in 54%. Mean pedal runoff was 5 (range, 2-8). Technical success was 96%.
The overall major adverse cardiac event rate was 6% and MALE was 38% at
30 days. Outcomes at 5 years were (mean  standard error of the mean)
clinical efficacy, 29% 1%; amputation-free survival, 29% 1%, andMALE,
31%  1%.
Conclusions: Tibial intervention for tissue loss in ESRD patients
requiring hemodialysis is associated with a very high MALE rate. Longer-
term outcomes remain relatively poor, with 30% success in patient-
centered outcomes at 5 years.
The Role of Ultrasound to Identify Nonthrombotic Lower Extremity
Pathology
Anil Hingorani,MD,1 Mohsin Khan, MD,2 Enrico Ascher, MD,1 Natalie
Marks, MD, RVT,2 Ed Aboian, MD,2 Robert Jimenez, MD,2 Theres Jacob,
PhD2. 1Lutheran Medical Center and 2Maimononides Medical Center,
Brooklyn, NY
Objective(s): Accreditation in peripheral venous testing can be ob-
tained based on femoropopliteal duplex ultrasound evaluation, and many
laboratories limit their examination to this segment only. This simplified
protocol detects acute femoropopliteal deep venous thrombosis (DVT) but
misses calf vein DVT, superficial venous thrombosis, chronic DVT, venous
reflux, and other nonvenous findings potentially responsible for pateints’
presenting conditions. A protocol limited to the femoropopliteal segment
results in additional unnecessary testing and can create patient dissatisfac-
tion. We evaluated the differences in the diagnosis between a limited
femoropopliteal vs a complete approach to the venous ultrasound evaluation
of the lower extremities in patients examined in an outpatient vascular
laboratory.
Methods: A database with the complete ultrasound examinations of
the lower extremity, including the common femoral, deep femoral, popli-
teal, tibial and peroneal veins, calf musclar veins, and great and small
saphenous veins, performed in 1208 consecutive patients from July 2009 to
February 2010 was queried.
Results: Of the 1208 patients, acute femoropopliteal DVT was found
in 20 (1.66%), acute infrapopliteal DVT in 36 (2.98%), chronic femoropop-
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